Equine Potomavac + Imrab - 4905.20

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

3850.0%

Death Rate

Active Ingredients

Equine Potomavac + Imrab - 4905.20

Administration Routes

IntramuscularUnknown

Species Affected

Horse 13

Most Affected Breeds

Quarter Horse 4

Icelandic Pony 1

Welsh Mountain Pony 1

Pony (unspecified) 1

Paint 1

Thoroughbred 1

Horse (other) 1

Arab 1

Appaloosa 1

Pony of the Americas 1

Most Reported Reactions

Death by euthanasia 5

Lack of efficacy - NOS 5

Lack of efficacy (bacteria) - NOS 3

Diarrhoea 2

Mouth ulcer 1

Fever 1

Colic 1

Infectious disease NOS 1

Hyperglycaemia 1

Hypocalcaemic condition 1

HYPERBILIRUBINEMIA 1

Lack of efficacy (bacteria) - Ehrlichia 1

Outcome Breakdown

Recovered/Normal

5 (38.5%)

Euthanized

5 (38.5%)

Outcome Unknown

3 (23.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.